|
End-of-day quote
NSE India S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 2,361.70 INR | +2.04% |
|
+6.73% | +73.08% |
| Market Cap | 448B 4.75B 4.31B 3.98B 3.59B 6.77B 7.01B 47.84B 18.97B 239B 17.83B 17.45B 760B | P/E 2027 * |
35.3x | P/E 2028 * | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 456B 4.83B 4.38B 4.05B 3.65B 6.89B 7.13B 48.64B 19.29B 243B 18.13B 17.75B 772B | EV / Sales 2027 * |
4.11x | EV / Sales 2028 * | 3.55x |
| Free-Float |
22.18% | Yield 2027 * |
0.17% | Yield 2028 * | 0.21% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| EMCURE | End-of-day quote | |
Bombay S.E.
| 544210 | Delayed |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | +2.04% | ||
| 1 week | +6.73% | ||
| Current month | +26.17% | ||
| 1 month | +26.39% | ||
| 3 months | +17.52% | ||
| 6 months | +42.53% | ||
| Current year | +73.08% |
| 1 week | 2,196.6 |  | 2,429.9 |
| 1 month | 1,716 | | 2,429.9 |
| Current year | 1,381 | | 2,429.9 |
| 1 year | 1,312.3 | | 2,429.9 |
| 3 years | 889 | | 2,429.9 |
| 5 years | 889 | | 2,429.9 |
| 10 years | 889 | | 2,429.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 23/07/2001 | |
| Chairman | 75 | 21/09/2026 | |
| Director/Board Member | 49 | 28/07/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +6.73% | +71.21% | - | 4.67B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,271B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 683B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 520B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 389B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 362B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 304B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 286B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 253B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.44% | +1.92% | +38.75% | +83.27% | 428B | |
| Weighted average by Cap. | +0.54% | +2.67% | +37.64% | +96.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 111B 1.17B 1.06B 985M 889M 1.67B 1.73B 11.83B 4.69B 59.18B 4.41B 4.32B 188B | 126B 1.33B 1.21B 1.12B 1.01B 1.9B 1.97B 13.44B 5.33B 67.22B 5.01B 4.9B 213B |
| Net income | 12.57B 133M 121M 112M 101M 190M 197M 1.34B 532M 6.72B 500M 490M 21.32B | 15.26B 162M 147M 136M 122M 231M 239M 1.63B 646M 8.15B 608M 595M 25.88B |
| Net Debt | 7.56B 80.15M 72.63M 67.18M 60.62M 114M 118M 807M 320M 4.04B 301M 294M 12.81B | -1.84B -19.48M -17.66M -16.33M -14.73M -27.77M -28.75M -196M -77.79M -981M -73.11M -71.56M -3.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₹2,361.70 | +2.04% | 294,538 |
| 12/11/26 | ₹2,314.40 | +3.67% | 964,929 |
| 11/11/26 | ₹2,232.40 | +0.73% | 212,376 |
| 09/11/26 | ₹2,216.20 | -2.80% | 260,165 |
| 08/11/26 | ₹2,280.00 | +3.04% | 135,552 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
